Clinical Trial

Home Monitor for AA Burden Detection IIT in TWN

Study acronym: FF108
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Primary Endpoint: * Early detection rate in Atrial Arrhythmia (AA) burden * Data transmission success rate for overall number of atrial burden collection during the monitoring period Secondary Endpoints: * Atrial burden occurrence at 3/6/12 months post-aATP * Incidence of arrhythmia * Safety: Immediate (\< 24 hours), in-hospital, 3 months, 6 months and 12 months adverse events
Trial Details
NCT Number NCT07572279
Lead Sponsor National Taiwan University Hospital
Collaborators: Biotronik SE & Co. KG
Conditions Paroxysmal Atrial Fibrillation (PAF), Atrial Flutter
Enrollment 30 participants
Start Date 2026-06-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-07